Literature DB >> 26185264

A Patient on Peritoneal Dialysis with Refractory Volume Overload.

Martin Wilkie1.   

Abstract

The management of volume in patients with diabetes on peritoneal dialysis is affected by several factors, including the degree of residual renal function, peritoneal membrane small-solute transport, salt and water intake, blood sugar control, comorbidity, and nutritional status. It requires sequential evaluation of volume status and adjustment of the peritoneal dialysis prescription on the basis of assessments of membrane function and alterations in urine volume. Steps should be taken to preserve residual renal function for as long as possible. Ultimately, in patients who have become anuric and have developed ultrafiltration failure, timely transfer to hemodialysis may be necessary, requiring discussion and planning with the patient.
Copyright © 2016 by the American Society of Nephrology.

Entities:  

Keywords:  diabetic nephropathy; dialysis volume; icodextrin; peritoneal dialysis; peritoneal membrane

Mesh:

Substances:

Year:  2015        PMID: 26185264      PMCID: PMC4702225          DOI: 10.2215/CJN.02920315

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  34 in total

1.  Effect of fluid and sodium removal on mortality in peritoneal dialysis patients.

Authors:  K Ateş; G Nergizoğlu; K Keven; A Sen; S Kutlay; S Ertürk; N Duman; O Karatan; A E Ertuğ
Journal:  Kidney Int       Date:  2001-08       Impact factor: 10.612

2.  What is the link between poor ultrafiltration and increased mortality in anuric patients on automated peritoneal dialysis? Analysis of data from EAPOS.

Authors:  Simon J Davies; Edwina A Brown; Werner Reigel; Elaine Clutterbuck; Olof Heimbürger; Nicanor Vega Diaz; George J Mellote; Javier Perez-Contreras; Renzo Scanziani; Christian D'Auzac; Dirk Kuypers; Jose C Divino Filho
Journal:  Perit Dial Int       Date:  2006 Jul-Aug       Impact factor: 1.756

3.  Clinical effects of combined therapy with peritoneal dialysis and hemodialysis.

Authors:  Hideki Kawanishi; Misaki Moriishi
Journal:  Perit Dial Int       Date:  2007-06       Impact factor: 1.756

4.  Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis.

Authors:  K Scott Brimble; Michelle Walker; Peter J Margetts; Kiran K Kundhal; Christian G Rabbat
Journal:  J Am Soc Nephrol       Date:  2006-08-02       Impact factor: 10.121

5.  Strict volume control normalizes hypertension in peritoneal dialysis patients.

Authors:  A I Günal; S Duman; M Ozkahya; H Töz; G Asçi; F Akçiçek; A Basçi
Journal:  Am J Kidney Dis       Date:  2001-03       Impact factor: 8.860

6.  Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study.

Authors:  Joanne M Bargman; Kevin E Thorpe; David N Churchill
Journal:  J Am Soc Nephrol       Date:  2001-10       Impact factor: 10.121

7.  Longitudinal membrane function in functionally anuric patients treated with APD: data from EAPOS on the effects of glucose and icodextrin prescription.

Authors:  Simon J Davies; Edwina A Brown; Niels E Frandsen; Anabela S Rodrigues; Ana Rodriguez-Carmona; Andreas Vychytil; Evelyne Macnamara; Agneta Ekstrand; Anders Tranaeus; Jose C Divino Filho
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

8.  Survival advantage of hemodialysis relative to peritoneal dialysis in patients with end-stage renal disease and congestive heart failure.

Authors:  Florence Sens; Anne-Marie Schott-Pethelaz; Michel Labeeuw; Cyrille Colin; Emmanuel Villar
Journal:  Kidney Int       Date:  2011-07-20       Impact factor: 10.612

Review 9.  Clinical value of standardized equilibration tests in CAPD patients.

Authors:  Z J Twardowski
Journal:  Blood Purif       Date:  1989       Impact factor: 2.614

10.  Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.

Authors:  Simon J Davies; Graham Woodrow; Kieron Donovan; Jörg Plum; Paul Williams; Ann Catherine Johansson; Hans-Peter Bosselmann; Olof Heimbürger; Ole Simonsen; Andrew Davenport; Anders Tranaeus; Jose C Divino Filho
Journal:  J Am Soc Nephrol       Date:  2003-09       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.